GlassScriptPhysician profile
Beno M Kuharich
NPI 1659407203
$16,801.15
in general payments reported to CMS, 2019-2025
14 companies · $459 in 2025
The $459 reported for 2025 was more than what 77% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,644 · 2020: $8,720 · 2021: $65.77 · 2022: $204 · 2023: $295 · 2024: $414 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,167.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $10,728.40 | 2019-2020 | |
| Boston Scientific Corporation | $4,335.49 | 2019-2023 | |
| Medtronic, INC. | $1,179.34 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Nevro Corp. | $230.43 | 2019-2024 | Senza |
| Saluda Medical Americas, INC. | $80.19 | 2024 | Evoke |
| Abbott Laboratories | $57.74 | 2025 | Eterna |
| Radius Health, INC. | $34.92 | 2019 | |
| Vertiflex, INC. | $34.10 | 2019 | |
| Si-Bone, INC. | $25.92 | 2023 | |
| Relievant Medsystems, INC. | $21.24 | 2023 | Intracept |
| Amgen INC. | $20.98 | 2019 | |
| Assertio Therapeutics, INC. | $18.08 | 2019 | |
| Tersera Therapeutics LLC | $17.55 | 2024 | Prialt |
| Allergan, INC. | $16.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beno Kuharich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.